Results 51 to 60 of about 274,125 (232)

Impact Of Vulvovaginal Atrophy Of Menopause In Spanish Women: Prevalence And Symptoms According To The EVES Study. [PDF]

open access: yesSex Med, 2019
Introduction: The prevalence of menopausal women with confirmed vulvovaginal atrophy (VVA) oscillates between 67–98%. Aim: To assess the prevalence of postmenopausal women with VVA confirmed by gynecologic clinical assessment among all women attending ...
Palacios S   +5 more
europepmc   +2 more sources

Comparison of anogenital distance and correlation with vulvo-vaginal atrophy: a pilot study on premenopausal and postmenopausal women [PDF]

open access: yes, 2018
OBJECTIVES: Anogenital distance (AGD) represents the space between labia posterior commissure and anus. This was pilot study to investigate how menopause and so lack of oestrogens affects AGD. METHODS: A total of 109 patients were enrolled.
Benedetti Panici, Pierluigi   +11 more
core   +1 more source

The therapeutic effect of dehydroepiandrosterone (DHEA) on vulvovaginal atrophy

open access: yesPharmacological Research, 2021
Vulvovaginal atrophy (VVA) is a chronic disease that mostly occurs in postmenopausal women. After menopause, insufficient sex hormones affect the anatomy of the vagina and cause drastic physiological changes. The main histopathological studies of VVA show that postmenopausal estrogen deficiency can lead to the increase of intermediate/parabasal cells ...
Jing, Wang, Ling, Wang
openaire   +2 more sources

Women’s Sexual Dysfunctions Following Stem Cell Transplant and the Impact on Couple Relationship

open access: yesLife, 2023
Stem cell transplant proved its efficacy in increasing the survival rate among young patients diagnosed with hematological malignancies. A transplant conditioning regimen is particularly destructive on the genital system, often determining premature ...
Mihaela Plotogea   +11 more
doaj   +1 more source

Managing menopausal symptoms and associated clinical issues in breast cancer survivors [PDF]

open access: yes, 2017
Objective: Review evidence to guide management of menopausal signs and symptoms in women after breast cancer and make recommendations accordingly. Evidence: Randomized controlled clinical trials, observational studies, evidence-based guidelines, and
Davis, Susan R.   +5 more
core   +1 more source

Immunolocalization of steroidogenic enzymes in the vaginal mucous of Galea spixii during the estrous cycle. [PDF]

open access: yes, 2017
BackgroundThe synthesis of sex steroids is controlled by several enzymes such as17α-hydroxylase cytochrome P450 (P450c17) catalyzing androgen synthesis and aromatase cytochrome P450 (P450arom) catalyzing estrogen synthesis, both of which must complex ...
Assis Neto, Antônio Chaves de   +5 more
core   +1 more source

Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy

open access: yesGynecological Endocrinology, 2021
It is estimated that 50% of women will suffer a severe form of vulvovaginal atrophy (VVA) related to menopause. Equally, young women may temporarily present this clinical problem while receiving various pharmacological or endocrine treatments or radiotherapy.To determine clinical and diagnostic exams required to confirm the presence of VVA (also ...
Faustino R. Pérez-López   +5 more
openaire   +2 more sources

Vulvovaginal atrophy in the peri- and post-menopause: relevance and impact on quality of life [PDF]

open access: yesГинекология, 2022
Vulvovaginal atrophy (VVA) is detected in more than 50% of postmenopausal women, and at 4049 years of age, 15-19% of women have relevant signs. Atrophic changes in the female urogenital system are associated with hypoestrogenism, which results in the ...
Mekan R. Orazov   +5 more
doaj   +1 more source

Profiles and technological requirements of urogenital probiotics [PDF]

open access: yes, 2015
Probiotics, defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host, are considered a valid and novel alternative for the prevention and treatment of female urogenital tract infections. Lactobacilli,
Juárez Tomás, María Silvina   +1 more
core   +1 more source

Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease

open access: yesGynecological Endocrinology, 2021
To develop a best practice document for the management of postmenopausal vulvovaginal atrophy (VVA).Literature review carried out using clinical terms, treatments or interventions and comorbidity related to VVA.There is a wide variety of interventions that may produce temporal benefits for VVA.
Faustino R. Pérez-López   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy